AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday. The findings from the new Phase 3 trial, which…
AstraZeneca vaccine shows 79% efficacy against symptomatic Covid-19 in new trial, company says
